Woodline Partners LP Pliant Therapeutics, Inc. Transaction History
Woodline Partners LP
- $17.6 Billion
- Q2 2025
A detailed history of Woodline Partners LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 2,348,526 shares of PLRX stock, worth $3.95 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,348,526
Previous 2,514,084
6.59%
Holding current value
$3.95 Million
Previous $3.39 Million
19.74%
% of portfolio
0.02%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding PLRX
# of Institutions
135Shares Held
60.5MCall Options Held
279KPut Options Held
7.1K-
Tang Capital Management LLC San Diego, CA6MShares$10.1 Million0.53% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$8.35 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.95MShares$6.63 Million0.16% of portfolio
-
Morgan Stanley New York, NY3.05MShares$5.13 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.01MShares$5.06 Million25.76% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $81.8M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...